Trials for new HIV prevention drug showed 99.9% of participants remained negative скачать в хорошем качестве

Trials for new HIV prevention drug showed 99.9% of participants remained negative

The U.S. Food and Drug Administration has approved a new HIV prevention medication that's been found to be highly effective. The drug is named Yeztugo by drug developer Gilead. CBS News medical contributor Dr. Celine Gounder has more. CBS News 24/7 is the premier anchored streaming news service from CBS News and Stations that is available free to everyone with access to the internet and is the destination for breaking news, live events, original reporting and storytelling, and programs from CBS News and Stations' top anchors and correspondents working locally, nationally and around the globe. It is available on more than 30 platforms across mobile, desktop and connected TVs for free, as well as CBSNews.com and Paramount+ and live in 91 countries. Subscribe to the CBS News YouTube channel:    / cbsnews   Watch CBS News: https://cbsnews.com/live/ Download the CBS News app: https://cbsnews.com/mobile/ Follow CBS News on Instagram:   / cbsnews   Like CBS News on Facebook:   / cbsnews   Follow CBS News on Twitter:   / cbsnews   Subscribe to our newsletters: https://cbsnews.com/newsletters/ Try Paramount+ free: https://paramountplus.com/?ftag=PPM-0... For video licensing inquiries, contact: licensing@veritone.com